Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Asset Utilization Ratio: 2009-2025

Historic Asset Utilization Ratio for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to 0.27.

  • China Pharma Holdings' Asset Utilization Ratio fell 31.47% to 0.27 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27, marking a year-over-year decrease of 31.47%. This contributed to the annual value of 0.29 for FY2024, which is 29.44% down from last year.
  • Latest data reveals that China Pharma Holdings reported Asset Utilization Ratio of 0.27 as of Q3 2025, which was down 12.77% from 0.31 recorded in Q2 2025.
  • Over the past 5 years, China Pharma Holdings' Asset Utilization Ratio peaked at 0.56 during Q1 2021, and registered a low of 0.27 during Q3 2025.
  • In the last 3 years, China Pharma Holdings' Asset Utilization Ratio had a median value of 0.40 in 2024 and averaged 0.39.
  • As far as peak fluctuations go, China Pharma Holdings' Asset Utilization Ratio rose by 28.07% in 2021, and later tumbled by 31.47% in 2025.
  • Over the past 5 years, China Pharma Holdings' Asset Utilization Ratio (Quarterly) stood at 0.47 in 2021, then climbed by 0.98% to 0.48 in 2022, then declined by 7.60% to 0.44 in 2023, then declined by 27.50% to 0.32 in 2024, then tumbled by 31.47% to 0.27 in 2025.
  • Its last three reported values are 0.27 in Q3 2025, 0.31 for Q2 2025, and 0.30 during Q1 2025.